DE69626118D1 - Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen - Google Patents

Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen

Info

Publication number
DE69626118D1
DE69626118D1 DE69626118T DE69626118T DE69626118D1 DE 69626118 D1 DE69626118 D1 DE 69626118D1 DE 69626118 T DE69626118 T DE 69626118T DE 69626118 T DE69626118 T DE 69626118T DE 69626118 D1 DE69626118 D1 DE 69626118D1
Authority
DE
Germany
Prior art keywords
pct
sulfonylcarbonates
lipoproteins
sulfonamides
lowering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626118T
Other languages
English (en)
Other versions
DE69626118T2 (de
Inventor
Robert Krause
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of DE69626118D1 publication Critical patent/DE69626118D1/de
Application granted granted Critical
Publication of DE69626118T2 publication Critical patent/DE69626118T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE69626118T 1995-08-04 1996-07-08 Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen Expired - Fee Related DE69626118T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US303195P 1995-08-04 1995-08-04
PCT/US1996/011366 WO1997005868A1 (en) 1995-08-04 1996-07-08 Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels

Publications (2)

Publication Number Publication Date
DE69626118D1 true DE69626118D1 (de) 2003-03-13
DE69626118T2 DE69626118T2 (de) 2003-11-27

Family

ID=21703764

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626118T Expired - Fee Related DE69626118T2 (de) 1995-08-04 1996-07-08 Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen

Country Status (27)

Country Link
US (1) US6117909A (de)
EP (1) EP0841913B1 (de)
JP (1) JPH11510184A (de)
KR (1) KR19990036127A (de)
CN (1) CN1192140A (de)
AT (1) ATE232097T1 (de)
AU (1) AU716255B2 (de)
BG (1) BG63863B1 (de)
CA (1) CA2221729A1 (de)
CZ (1) CZ26198A3 (de)
DE (1) DE69626118T2 (de)
DK (1) DK0841913T3 (de)
EA (1) EA002435B1 (de)
EE (1) EE9800037A (de)
ES (1) ES2191762T3 (de)
GE (1) GEP20012511B (de)
HR (1) HRP960341A2 (de)
HU (1) HUP9900668A3 (de)
IL (1) IL122247A0 (de)
NO (1) NO980466L (de)
NZ (1) NZ312571A (de)
PL (1) PL185943B1 (de)
PT (1) PT841913E (de)
SK (1) SK12598A3 (de)
UA (1) UA46030C2 (de)
WO (1) WO1997005868A1 (de)
ZA (1) ZA966617B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1584333A3 (de) * 1998-01-28 2009-04-29 Warner-Lambert Company LLC Verwendung von Acetylcoenzyme A Inhibitoren zur Behandlung von Alzheimer
SK502001A3 (en) * 1998-07-21 2002-06-04 Warner Lambert Co Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
IT1303249B1 (it) * 1998-10-23 2000-11-06 Dompe Spa Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono.
PL355148A1 (en) * 1999-11-05 2004-04-05 Warner-Lambert Company Prevention of plaque rupture by acat inhibitors
CA2369967A1 (en) * 2001-02-12 2002-08-12 Joseph Anthony Cornicelli Methods of treating nuclear factor-kappa b mediated diseases and disorders
AR037097A1 (es) 2001-10-05 2004-10-20 Novartis Ag Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
US6939224B2 (en) * 2002-03-12 2005-09-06 Igt Gaming device having varying risk player selections
EP3709986B1 (de) 2017-11-14 2023-11-01 Merck Sharp & Dohme LLC Neuartige substituierte biarylverbindungen als indolamin-2,3-dioxygenase(ido)-inhibitoren
MX2020004930A (es) 2017-11-14 2020-08-27 Merck Sharp & Dohme Compuestos de biarilo sustituido novedosos como inhibidores de indolamina 2,3-dioxigenasa (ido).

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003106A (en) * 1983-07-19 1991-03-26 American Cyanamid Company Antiatherosclerotic ureas and thioureas
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
DK0555351T3 (da) * 1990-10-30 1995-06-06 Warner Lambert Co Oxysulfonylcarbamater
IL101785A0 (en) * 1991-05-10 1992-12-30 Fujisawa Pharmaceutical Co Urea derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds

Also Published As

Publication number Publication date
HUP9900668A2 (hu) 1999-06-28
NZ312571A (en) 2000-07-28
EP0841913B1 (de) 2003-02-05
EA199800176A1 (ru) 1998-10-29
EA002435B1 (ru) 2002-04-25
CN1192140A (zh) 1998-09-02
DK0841913T3 (da) 2003-05-05
CZ26198A3 (cs) 1998-07-15
EE9800037A (et) 1998-08-17
PL185943B1 (pl) 2003-09-30
BG102222A (en) 1998-09-30
ES2191762T3 (es) 2003-09-16
UA46030C2 (uk) 2002-05-15
GEP20012511B (en) 2001-08-27
EP0841913A1 (de) 1998-05-20
BG63863B1 (bg) 2003-04-30
ATE232097T1 (de) 2003-02-15
ZA966617B (en) 1997-02-18
KR19990036127A (ko) 1999-05-25
WO1997005868A1 (en) 1997-02-20
PT841913E (pt) 2003-06-30
NO980466D0 (no) 1998-02-03
PL324908A1 (en) 1998-06-22
NO980466L (no) 1998-02-03
SK12598A3 (en) 1999-02-11
AU716255B2 (en) 2000-02-24
HRP960341A2 (en) 1998-02-28
US6117909A (en) 2000-09-12
CA2221729A1 (en) 1997-02-20
DE69626118T2 (de) 2003-11-27
IL122247A0 (en) 1998-04-05
HUP9900668A3 (en) 2000-08-28
JPH11510184A (ja) 1999-09-07
AU6454196A (en) 1997-03-05

Similar Documents

Publication Publication Date Title
FI955438A0 (fi) N-asyylisulfamidihappoesterit (tai -tioesterit), N-asyylisulfonamidit ja N-sulfonyylikarbamiinihappoesterit (tai -tioesterit) hyperkolesteroleemisina aineina
DE69629184D1 (de) Verwendung von vitamin d2 oder vitamin d4-derivaten zur herstellung eines medikamentes zur behandlung des sekundären hyperparathyroidismus
KR890003671A (ko) 신규 항우울제
DE69430816T2 (de) Verwendung von Piperidin-Derivaten in der Behandlung von Schizophrenie
DE60011462D1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
DE69626118D1 (de) Verwendung von sulfaminsäuren derivaten, acrylsulfonamiden oder sulfonylcarbonaten zur herstellung eines arzneimittels zur senkung des spiegels von lipoproteinen
ATE191849T1 (de) Verwendung von (s)-(-)-alpha-ethyl-2-oxo-1- pyrrolidinacetamid zur herstellung eines medikaments zur behandlung von angst
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
DE69420832D1 (de) Die Verwendung von Carbostyrilderivaten zur Herstellung eines Arzneimittels zur Hemmung der Produktion von Interleukin-8
ATE189203T1 (de) Trizyklische derivate, ihre herstellung, ihre verwendung zur herstellung von optisch aktivem oder racemischem colchizin, thiocolchizin, dessen analoge oder derivate, und intermediate
MX9709275A (es) Uso de los derivados del acido sulfamico, carbamatos acil sulfonamidas o sulfonil para la manufactura de un medicamento para disminuir los niveles de lipoproteinas.
ATE216235T1 (de) Verwendung von cholinesterase-inhibitoren für die herstellung eines medikaments zur behandlung von xerostomie
ATE181503T1 (de) Verwendung von idazoxan und derivaten zur herstellung eines arzneimittels zur behandlung von parkinsonismus und seiner evolution
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
ATE122674T1 (de) Ethanoladdukte von 6-sulfonylsubstituierten 3- hydroxychromanen und ihre verwendung als inhalationsmittel bei krankheiten.
HUP0001637A2 (hu) Görcsoldó hatású származékok alkalmazása psoriasis kezelésére használható gyógyszerkészítmények előállítására
SE9401965D0 (sv) New compounds
DE69731090D1 (de) Thienylcyclohexan-derivte zur herstellung von thienylcyclohexylen
ATE195422T1 (de) Verwendung von piperazinderivaten zur behandlung von kognitiven erkrankungen
ATE92077T1 (de) Enzymhemmer und methode zu dessen herstellung.
DE69214180T2 (de) Verwendung von Bis-(p-Hydroxyphenylthio)methanderivaten zur Hemmung der fortschreitenden Entwicklung von insulinabhängingem Diabetes mellitus
DE69117438T2 (de) Verfahren zur Herstellung von insektiziden, nematiziden und akariziden, in 4-Stellung substituierten 5-(Trifluormethyl) pyrrol-3-nitril-Verbindungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee